The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial.

cholesterol fasting blood glucose hydrogen water inflammation metabolism oxidative stress

Journal

Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585

Informations de publication

Date de publication:
2020
Historique:
received: 26 11 2019
accepted: 03 03 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 11 4 2020
Statut: epublish

Résumé

Metabolic syndrome is associated with several medical risk factors including dyslipidemia, hyperglycemia, and obesity, which has become a worldwide pandemic. The sequelae of this condition increase the risk of cardiovascular and neurological disease and increased mortality. Its pathophysiology is associated with redox dysregulation, excessive inflammation, and perturbation of cellular homeostasis. Molecular hydrogen (H We conducted a randomized, double-blinded, placebo-controlled trial in 60 subjects (30 men and 30 women) with metabolic syndrome. An initial observation period of one week was used to acquire baseline clinical data followed by randomization to either placebo or high-concentration HRW (> 5.5 millimoles of H Supplementation with high-concentration HRW significantly reduced blood cholesterol and glucose levels, attenuated serum hemoglobin A1c, and improved biomarkers of inflammation and redox homeostasis as compared to placebo ( Our results give further credence that high-concentration HRW might have promising effects as a therapeutic modality for attenuating risk factors of metabolic syndrome.

Identifiants

pubmed: 32273740
doi: 10.2147/DMSO.S240122
pii: 240122
pmc: PMC7102907
doi:

Types de publication

Journal Article

Langues

eng

Pagination

889-896

Informations de copyright

© 2020 LeBaron et al.

Déclaration de conflit d'intérêts

TWL reports personal fees from medical/academic conferencesincluding travel reimbursement, honoraria, and speaking and consultancy fees from various academic and commercial entities regarding molecular hydrogen. All other authors report no conflict of interest.

Références

Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):688-693
pubmed: 30982748
Biochem Biophys Res Commun. 2008 Dec 26;377(4):1195-8
pubmed: 18996093
Transl Res. 2017 May;183:57-70
pubmed: 28130064
PLoS One. 2013;8(1):e53913
pubmed: 23326534
Sci Rep. 2013 Nov 20;3:3273
pubmed: 24253616
J Lipid Res. 2013 Jul;54(7):1884-93
pubmed: 23610159
Front Pharmacol. 2016 Oct 27;7:392
pubmed: 27833552
J Atheroscler Thromb. 2018 Jan 1;25(1):27-39
pubmed: 28966336
Neurochem Res. 2017 Sep;42(9):2658-2665
pubmed: 28462451
Theranostics. 2017 Mar 7;7(5):1330-1332
pubmed: 28435468
Nutr Res. 2008 Mar;28(3):137-43
pubmed: 19083400
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Biol Sex Differ. 2016 May 18;7:26
pubmed: 27195103
NPJ Aging Mech Dis. 2016 Apr 28;2:16008
pubmed: 28721265
Oxid Med Cell Longev. 2012;2012:353152
pubmed: 22720117
Can J Physiol Pharmacol. 2020 Jan;98(1):29-34
pubmed: 31536712
Obesity (Silver Spring). 2011 Jul;19(7):1396-403
pubmed: 21293445
World J Gastroenterol. 2018 Dec 7;24(45):5095-5108
pubmed: 30568387
Clinics (Sao Paulo). 2008 Aug;63(4):427-32
pubmed: 18719750
Can J Physiol Pharmacol. 2019 Apr;97(4):287-292
pubmed: 30543459
Ir J Med Sci. 2018 Feb;187(1):85-89
pubmed: 28560519
J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2587-2594
pubmed: 28669654
Rev Diabet Stud. 2006 Fall;3(3):118-26
pubmed: 17487335
Curr Alzheimer Res. 2018 Mar 14;15(5):482-492
pubmed: 29110615
Can J Physiol Pharmacol. 2019 Sep;97(9):857-862
pubmed: 31251888
Can J Physiol Pharmacol. 2019 Sep;97(9):797-807
pubmed: 30970215
Obes Rev. 2015 Jan;16(1):1-12
pubmed: 25407540
J Clin Biochem Nutr. 2010 Mar;46(2):140-9
pubmed: 20216947
Molecules. 2019 May 31;24(11):
pubmed: 31159153
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2813-20
pubmed: 23152494
PLoS One. 2009 Sep 30;4(9):e7247
pubmed: 19789628
J Lifestyle Med. 2019 Jan;9(1):36-43
pubmed: 30918832
Ann Med. 2015 Jun;47(4):301-4
pubmed: 25936365
Nat Med. 2007 Jun;13(6):688-94
pubmed: 17486089
Gastroenterology. 1992 Apr;102(4 Pt 1):1424-6
pubmed: 1551553
Biochem Biophys Res Commun. 2017 Nov 4;493(1):318-324
pubmed: 28890349

Auteurs

Tyler W LeBaron (TW)

Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Molecular Hydrogen Institute, Enoch, UT, USA.

Ram B Singh (RB)

Hospital and Research Institute, Moradabad, India.

Ghizal Fatima (G)

Era Medical College, Lucknow, India.

Kumar Kartikey (K)

Hospital and Research Institute, Moradabad, India.

Jagdish P Sharma (JP)

Hospital and Research Institute, Moradabad, India.

Sergej M Ostojic (SM)

Applied Bioenergetics Lab, Faculty of Sport and PE, University of Novi Sad, Novi Sad, Serbia.
Faculty of Health Sciences, University of Pécs, Pécs, Hungary.

Anna Gvozdjakova (A)

Medical Faculty, Pharmacobiochemical Laboratory of 3rd Medical Department, Comenius University Bratislava, Bratislava, Slovakia.

Branislav Kura (B)

Molecular Hydrogen Institute, Enoch, UT, USA.

Mami Noda (M)

Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

Viliam Mojto (V)

Third Internal Clinic, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Mohammad Arif Niaz (MA)

Center of Nutrition Research, International College of Nutrition, Moradabad, India.

Jan Slezak (J)

Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Classifications MeSH